HYBRIGENICS SA

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 10245
 
 
 
C07D HETEROCYCLIC COMPOUNDS 3159
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 247
 
 
 
C07K PEPTIDES 2134
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 2123
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 1137
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 1166
 
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 198
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1205

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2012/0015,915 FORMULATIONS OF 14-EPI-ANALOGUES OF VITAMIN DJul 13, 11Jan 19, 12[A61K, A61P]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9546150 Substituted quinazolin-4-ones for inhibiting ubiquitin specific protease 7Aug 29, 12Jan 17, 17[A61K, C07D]
9328093 Selective inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applicationsSep 17, 14May 03, 16[A61K, C07D]
9314474 Formulations of 14-epi-analogues of vitamin DJul 13, 11Apr 19, 16[A61K, A61P]
9315455 Process for isomerizing fused bicyclic structures and preparation of vitamin D analogs comprising the sameJan 24, 11Apr 19, 16[C07C]
8648076 Cysteine protease inhibitors and their therapeutic applicationsJul 26, 06Feb 11, 14[A61K, A01N, C07D]
8481514 Therapeutical uses of inecalcitolMay 18, 10Jul 09, 13[A61K]
7875613 Tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applicationsOct 30, 06Jan 25, 11[A61K, C07D, C12N]
7462615 Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applicationsDec 08, 05Dec 09, 08[A61K]
7459434 Peptide interacting with anti-apoptotic proteins of the Bcl-2 familyAug 04, 04Dec 02, 08[A61K]
6916615 Collection of prokaryotic DNA for two hybrid systems Helicobacter pylori protein-protein interactions and application thereofOct 30, 01Jul 12, 05[C12Q, C12P, G01N]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2013/0023,521 NOVEL SELECTIVE INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7, THE PHARMACEUTICAL COMPOSITIONS THEREOF AND THEIR THERAPEUTIC APPLICATIONSAbandonedJan 17, 11Jan 24, 13[A61K, C07D, A61P]
2012/0015,913 Formulations of 14-EPI-Analogues of Vitamin DAbandonedJul 15, 10Jan 19, 12[A61K, C07C, A61P]
2011/0237,644 UBIQUITIN SPECIFIC PROTEASES RESPONSIBLE FOR MCL-1 STABILITY AND USES THEREOFAbandonedOct 29, 09Sep 29, 11[A61K, C12Q, C12N, A61P]
2011/0177,105 Novel Selective Inhibitors of Ubiquitin Specific Protease 7, the Pharmaceutical Compositions Thereof and Their Therapeutic ApplicationsAbandonedAug 13, 10Jul 21, 11[A61K, C07D, A61P]
7927813 Peptides which interact with anti-apoptotic members of the Bcl-2 protein family, and usesExpiredJan 31, 06Apr 19, 11[G01N, C07K]
7919233 Motif of the beclin protein which interacts with anti-apoptotic members of the Bcl-2 protein family, and usesExpiredJan 31, 06Apr 05, 11[G01N]
2010/0048,575 NOVEL TETRACYCLIC INHIBITORS OF CYSTEINE PROTEASES, THE PHARMACEUTICAL COMPOSITIONS THEREOF AND THEIR THERAPEUTIC APPLICATIONSAbandonedOct 25, 07Feb 25, 10[A61K, C07D, A61P]
2009/0181,972 Novel Inhibitors of Cysteine Proteases, the Pharmaceutical Compositions Thereof and their Therapeutic ApplicationsAbandonedDec 05, 06Jul 16, 09[A61K, C07D, A61P]
2007/0166,778 Substrates and methods for assaying deubiquitinating enzymesAbandonedJan 12, 07Jul 19, 07[C07H, C12Q, C12P, C12N]
2007/0032,499 Novel cysteine protease inhibitors and their therapeutic applicationsAbandonedAug 05, 05Feb 08, 07[A61K, C07D]
6977144 Sid nucleic acids and polypeptides selected from a pathogenic strain of hepatitis C virus and applications thereofExpiredAug 02, 01Dec 20, 05[C12Q, C12N, C07K]
2004/0029,223 Bacterial two-hybrid system for protein interaction screeningAbandonedJun 30, 03Feb 12, 04[C12P]
2003/0232,421 Protein-protein interactions in adipocyte cells (3)AbandonedMay 06, 02Dec 18, 03[A61K, C07H, C12P, C12N, G01N]
2003/0220,928 Method for organizing and querying a genomic and proteomic databasesAbandonedMay 21, 02Nov 27, 03[G06F]
2003/0167,131 Method for constructing, representing or displaying protein interaction maps and data processing tool using this methodAbandonedFeb 25, 03Sep 04, 03[G06F]
2003/0148,381 More protein-protein interactions in the inner earAbandonedJun 21, 02Aug 07, 03[A61K, C07H, C12P, C12N, G01N, C07K]
2003/0055,220 Protein-protein interactions between Shigella flexneri polypeptides and mammalian polypeptidesAbandonedJan 11, 02Mar 20, 03[C07K]
2003/0040,089 Protein-protein interactions in adipocyte cellsAbandonedJan 02, 02Feb 27, 03[C07H, C12N, G01N, G06F]
2003/0032,066 Protein-protein interaction map inference using interacting domain profile pairsAbandonedMar 19, 02Feb 13, 03[G01N, G06G]
2003/0007,956 Proteins that interact with betaTrCPAbandonedDec 18, 01Jan 09, 03[A61K, C12P, C12N]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.